Notice of Meeting, 34772 [05-11749]

Download as PDF 34772 Federal Register / Vol. 70, No. 114 / Wednesday, June 15, 2005 / Notices capital or other non-labor costs associated with the document requests are minimal. Covered entities will already be equipped to provide written notices (e.g., computers with word processing programs, typewriters, copying machines, mailing capabilities). Most likely, only entities that already have on-line capabilities will offer consumers the choice to receive notices via electronic format. As such, these entities will already be equipped with the computer equipment and software necessary to disseminate the required disclosures via electronic means. William Blumenthal, General Counsel. [FR Doc. 05–11748 Filed 6–14–05; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Meeting In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting. A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications for the Limited Competition Supplement Funds to Centers for Education and Research on Therapeutics (CERTs) for Developing Effectiveness Research Methodologies and Measures (RFA–HS–SUPP–1) are to be reviewed and discussed at this meeting. These discussions are likely to reveal personal information concerning individuals associated with the applications. This information is exempt from mandatory disclosure under the above-cited statutes. VerDate jul<14>2003 17:57 Jun 14, 2005 Jkt 205001 SEP Meeting on: The Limited Competition Supplement Funds to Centers for Education and Research on Therapeutics (CERTs) for Developing Effectiveness Research Methodologies and Measures. Date: July 29, 2006 (open on July 29 from 10 a.m. to 10:15 a.m. and closed for the remainder of the meeting). Place: John M. Eisenberg Building, AHRQ Conference Center, 540 Gaither Road, Rockville, Maryland 20850. Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the non-confidential portions of this meeting should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone (301) 427– 1554. Agenda items for this meeting are subject to change as priorities dictate. Dated: June 7, 2005. Carolyn M. Clancy, Director. [FR Doc. 05–11749 Filed 6–13–05; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 70 FR 30120–30121, dated May 25, 2005) is amended to reflect the establishment of the Office of Workforce and Career Development within the Office of the Director, Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: After the mission statement for the Office of the Chief Science Officer (CAS), insert the following: Office of Workforce and Career Development (CAL). The mission of the Office of Workforce and Career Development (OWCD) is to improve health outcomes by ensuring a competent and sustainable workforce through excellence and innovation in PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 workforce and career development. In carrying out its mission, OWCD: (1) Develops goals and objectives, and provides leadership, policy formation, scientific oversight, and guidance in program planning and development; (2) plans, directs, and manages CDC-wide training programs, and internship and fellowship programs; (3) provides consultation, technical assistance, and training on epidemiology, public health informatics, and prevention effectiveness to CDC/ATSDR, states, other agencies, other countries, and domestic and international organizations; (4) develops, designs, and implements an accredited comprehensive strategic human resource leadership development and career management program for all occupational series throughout CDC; organizational development, career management, employee development, and training; (5) maximizes economies of scale through systematic planning and evaluation of agency-wide training initiatives to assist CDC employees in achieving required competencies; (6) assists in the definition and analysis of training needs of public health workers, and develops and evaluates instructional products designed to meet those needs; (7) works with partners, internally and externally, to develop a strategic vision for the public health workforce; (8) collaborates with the Office of Strategy and Innovation (OSI) to develop workforce goals for all of CDC/ATSDR; (9) coordinates the Excellence in Learning Council to coordinate, inform, and share strategic vision for all of CDC’s Coordinating Centers/Coordinating Offices (CC/CO); (10) conducts internal succession planning, forecasting services, and environmental scanning to ascertain both current and future public health workforce needs; and (11) in carrying out the above functions, collaborates, as appropriate, with the CDC Office of the Director, CDC CC/COs, domestic and international agencies and organizations. Office of the Director (CAL1). (1) Provides leadership and overall direction for OWCD; (2) develops goal and objectives, and provides leadership, policy formation, scientific oversight, and guidance in program planning and development; (3) plans, coordinates, and develops research plans for OWCD; (4) provides scientific leadership OWCD research-related activities; (5) ensures adherence to CDC and HHS sciencerelated policies, e.g., ethical conduct of research, information security, extramural research, data sharing; and responds to allegations of scientific E:\FR\FM\15JNN1.SGM 15JNN1

Agencies

[Federal Register Volume 70, Number 114 (Wednesday, June 15, 2005)]
[Notices]
[Page 34772]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-11749]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

    In accordance with section 10(d) of the Federal Advisory Committee 
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care 
Policy and Research Special Emphasis Panel (SEP) meeting.
    A Special Emphasis Panel is a group of experts in fields related to 
health care research who are invited by the Agency for Healthcare 
Research and Quality (AHRQ), and agree to be available, to conduct on 
an as needed basis, scientific reviews of applications for AHRQ 
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of 
time. Rather, they are asked to participate in particular review 
meetings which require their type of expertise.
    Substantial segments of the upcoming SEP meeting listed below will 
be closed to the public in accordance with the Federal Advisory 
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 
552b(c)(6). Grant applications for the Limited Competition Supplement 
Funds to Centers for Education and Research on Therapeutics (CERTs) for 
Developing Effectiveness Research Methodologies and Measures (RFA-HS-
SUPP-1) are to be reviewed and discussed at this meeting. These 
discussions are likely to reveal personal information concerning 
individuals associated with the applications. This information is 
exempt from mandatory disclosure under the above-cited statutes.
    SEP Meeting on: The Limited Competition Supplement Funds to Centers 
for Education and Research on Therapeutics (CERTs) for Developing 
Effectiveness Research Methodologies and Measures.
    Date: July 29, 2006 (open on July 29 from 10 a.m. to 10:15 a.m. and 
closed for the remainder of the meeting).
    Place: John M. Eisenberg Building, AHRQ Conference Center, 540 
Gaither Road, Rockville, Maryland 20850.
    Contact Person: Anyone wishing to obtain a roster of members, 
agenda or minutes of the non-confidential portions of this meeting 
should contact Mrs. Bonnie Campbell, Committee Management Officer, 
Office of Extramural Research, Education and Priority Populations, 
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone 
(301) 427-1554.
    Agenda items for this meeting are subject to change as priorities 
dictate.

    Dated: June 7, 2005.
Carolyn M. Clancy,
Director.
[FR Doc. 05-11749 Filed 6-13-05; 8:45 am]
BILLING CODE 4160-90-M